CIPP Liners: Quality Assurance for Sustainable Rehabilitation

This presentation will underscore the importance of independent testing in quality assurance for Cured-in-Place Pipe (CIPP) liners, a key component in sustainable infrastructure rehabilitation. We will discuss how rigorous testing of these liners not only ensures their effectiveness and longevity, but also contributes to more sustainable rehabilitation practices compared to traditional digging methods.

Dr. Michael Hoffmann pursued his studies in chemistry in Germany and received his PhD in Analytical Chemistry at the Helmholtz-Institute for Pharmaceutical Research Saarland. His work focused on ‘Mass Spectrometry in Natural Product Research’. He continued at the same institute as a postdoctoral researcher, where he evaluated alternative natural product screening approaches.
In 2018, Dr. Hoffmann began his industrial career at BASF SE. As the Lab Head of Metabolomics & Proteomics, he developed and implemented mass spectrometry-based methods in metabolomics and proteomics. After three years, he took on the leadership of a lab focusing on metabolomics and three other analytical labs providing fast results for research and process development.
In 2021, he joined Boehringer Ingelheim as Head of in vivo Drug Metabolism in the DMPK department. He led authorization-relevant Phase I and II work packages to elucidate the metabolism of drugs under development.
Since 2024, he has been the managing director of SBKS GmbH & Co. KG, a company he had been a long-standing member of during his studies. With this position, Dr. Hoffmann initiated the company takeover.